Drug Discovery and Development Analysis & Statistics, January 2013 (p40)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

1171-1210 of about 2 800 reports

Purchase Reports From Reputable Market Research Publishers

Poly (ADP-Ribose) Polymerase 2 (PARP-2) Inhibitors -Pipeline Insights, 2014

Poly (ADP-Ribose) Polymerase 2 (PARP-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Poly (ADP-Ribose) Polymerase 2 (PARP-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
PPAR-Beta / Delta Agonists -Pipeline Insights, 2014

PPAR-Beta / Delta Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PPAR-Beta / Delta Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Prolactin Receptor Antagonists -Pipeline Insights, 2014

Prolactin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prolactin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2014

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Prostaglandin Antagonists -Pipeline Insights, 2014

Prostaglandin Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists -Pipeline Insights, 2014

Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists -Pipeline Insights, 2014

Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists -Pipeline Insights, 2014

Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E2 (PGE2) Receptor Antagonists -Pipeline Insights, 2014

Prostaglandin E2 (PGE2) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E2 (PGE2) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists -Pipeline Insights, 2014

Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2014

Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin F2-Alpha Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Purine Nucleoside Phosphorylase (PNPase) Inhibitors -Pipeline Insights, 2014

Purine Nucleoside Phosphorylase (PNPase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Purine Nucleoside Phosphorylase (PNPase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Purinergic Receptor (Purinoceptor) Antagonists -Pipeline Insights, 2014

Purinergic Receptor (Purinoceptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Purinergic Receptor (Purinoceptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Pyrimidine Analogues -Pipeline Insights, 2014

Pyrimidine Analogues -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Pyrimidine Analogues-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
R2 Subunit Of Ribonucleotide Reductase Inhibitors -Pipeline Insights, 2014

R2 Subunit Of Ribonucleotide Reductase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“R2 Subunit Of Ribonucleotide Reductase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Raf/MEK/ERK Signaling Cascade Inhibitirs -Pipeline Insights, 2014

Raf/MEK/ERK Signaling Cascade Inhibitirs -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Raf/MEK/ERK Signaling Cascade Inhibitirs-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Receptor For Advanced Glycation End Product (RAGE) Inhibitors -Pipeline Insights, 2014

Receptor For Advanced Glycation End Product (RAGE) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Receptor For Advanced Glycation End Product (RAGE) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
Renin Inhibitors -Pipeline Insights, 2014

Renin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Renin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Retinoic Acid Receptors Alpha (RARs) Agonists -Pipeline Insights, 2014

Retinoic Acid Receptors Alpha (RARs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoic Acid Receptors Alpha (RARs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Retinoic Acid Receptors Beta  (RARs) Agonists -Pipeline Insights, 2014

Retinoic Acid Receptors Beta (RARs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoic Acid Receptors Beta (RARs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Retinoic Acid Receptors Gamma (RARs) Agonists -Pipeline Insights, 2014

Retinoic Acid Receptors Gamma (RARs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoic Acid Receptors Gamma (RARs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Retinoid x receptors (RXRs) Agonists -Pipeline Insights, 2014

Retinoid x receptors (RXRs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoid x receptors (RXRs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Reversible Anticholinesterases -Pipeline Insights, 2014

Reversible Anticholinesterases -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Reversible Anticholinesterases-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Ribosome Inhibitors -Pipeline Insights, 2014

Ribosome Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ribosome Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Sclerostin Inhibitors -Pipeline Insights, 2014

Sclerostin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Sclerostin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Secretase inhibitors -Pipeline Insights, 2014

Secretase inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Secretase inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Selectin Inhibitors -Pipeline Insights, 2014

Selectin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selectin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Selective COX Inhibitors -Pipeline Insights, 2014

Selective COX Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective COX Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Selective COX-2 Inhibitors -Pipeline Insights, 2014

Selective COX-2 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective COX-2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Selective Dipeptidyl Peptidase-4 (DPP-4) Inhibitors -Pipeline Insights, 2014

Selective Dipeptidyl Peptidase-4 (DPP-4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective Dipeptidyl Peptidase-4 (DPP-4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development

84 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.